Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

British Journal of Haematology
Johan MaertensJohan Van Eldere

Abstract

The recent advent of an improved commercial serum enzyme-linked immunosorbent assay (ELISA) for the detection of circulating galactomannan (GM), a major constituent of Aspergillus cell walls, has contributed to the diagnosis of invasive aspergillosis (IA) in many haematology and transplant centres. However, the optimal threshold for positivity remains a matter of debate. We prospectively evaluated the impact of lowering the cut-off in 124 neutropenic episodes with a high pretest probability for IA. Two new cut-off points, lower than previously accepted, are proposed: (a) a 'static' cut-off at 0.8 and (b) a 'dynamic' cut-off at 0.5. A single assay with an optical density (OD) index > or = 0.8 warrants the initiation of anti-Aspergillus therapy. A further lowering of the 'static' threshold seems not clinically feasible given the drop in positive predictive value (PPV). However, the demonstration of at least two sequential sera with an OD > or = 0.5 ('dynamic' threshold) increased the specificity and the PPV to 98.6% and the efficiency to 98%. Applying both cut-offs to a subgroup of 21 'possible' fungal infections further identified and upgraded six cases of IA. However, the clinical benefit of lower cut-offs (particularly for ear...Continue Reading

Associated Clinical Trials

References

May 1, 1977·Annals of Internal Medicine·J AisnerS C Schimpff
Jun 1, 1992·Infection and Immunity·D StynenJ P Latgé
Jan 1, 1995·Respiration; International Review of Thoracic Diseases·M von EiffJ van de Loo
Feb 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A SulahianF Derouin
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D W Denning
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D CaillotH Guy
Mar 4, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P RibaudE Gluckman
Jun 7, 2000·Lancet·D W Denning
Jul 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P H ChandrasekarE Manavathu
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J LinS M Teutsch
Oct 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Singh
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Feb 14, 2002·British Journal of Haematology·Rodrigo MartinoUNKNOWN alloPBSCT Infectious/Non-infectious Complications Subcommittees of the Grupo Español de Trasplante Hematopoyético (GETH)
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Raoul HerbrechtErmanno Candolfi
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elisabeth A HagenMindy G Schuster
Dec 12, 2003·The New England Journal of Medicine·Annie SulahianPatricia Ribaud
Feb 28, 2004·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L J Wheat
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claudio ViscoliAndrea Bacigalupo
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olivier AdamElisabeth Chachaty
Jun 3, 2004·The Lancet Infectious Diseases·Monique A S H Mennink-KerstenPaul E Verweij

❮ Previous
Next ❯

Citations

Jul 25, 2007·Intensive Care Medicine·R J TrofA B J Groeneveld
Nov 15, 2007·Current Infectious Disease Reports·L Joseph Wheat
May 1, 2010·International Journal of Hematology·Yuki Asano-Mori
Jul 24, 2008·Bone Marrow Transplantation·E CastagnolaC Viscoli
Aug 23, 2005·Medical Mycology·P E Verweij
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrWendy Leisenring
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan MaertensJohan Van Eldere
Apr 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher D PfeifferNasia Safdar
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johan A MaertensPaul E Verweij
Apr 20, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J Anaissie
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marisa H MiceliElias Anaissie
Sep 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M RuhnkeUNKNOWN Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology
Jan 5, 2011·The Journal of Antimicrobial Chemotherapy·Manuel Cuenca-EstrellaThomas R Rogers
Dec 28, 2007·Journal of Clinical Microbiology·Florence PersatAnnie Sulahian
Feb 12, 2010·Journal of Clinical Microbiology·Sophia KooFrancisco M Marty
Sep 8, 2005·Journal of Clinical Microbiology·Arlo UptonKieren A Marr
Apr 21, 2012·American Journal of Respiratory and Critical Care Medicine·Stijn I BlotUNKNOWN AspICU Study Investigators
Jul 29, 2006·Annals of Clinical Microbiology and Antimicrobials·Ridvan AliAhmet Tunali
Mar 13, 2013·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·O AtesB Tokgoz
Feb 20, 2014·Médecine et maladies infectieuses·G DesoubeauxJ Chandenier
Aug 29, 2013·Case Reports in Transplantation·Sonia RadunzFuat H Saner
Apr 17, 2013·Enfermedades infecciosas y microbiología clínica·Almudena Martín-PeñaJosé Miguel Cisneros
Jul 14, 2011·Critical Reviews in Microbiology·Joe L HsuDavid A Stevens
Mar 4, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Veronique DinandAnupam Sachdeva
May 27, 2014·Clinics in Laboratory Medicine·Frédéric Lamoth, Barbara D Alexander
Apr 6, 2011·Enfermedades infecciosas y microbiología clínica·Javier PemánRafael Zaragoza
Apr 7, 2009·Medicina clínica·José MensaMiguel Angel Sanz
Apr 21, 2009·Clinics in Chest Medicine·L Joseph Wheat
Dec 17, 2008·International Journal of Antimicrobial Agents·Manuel Cuenca-EstrellaJuan Luis Rodriguez-Tudela

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Raoul HerbrechtErmanno Candolfi
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christopher D PfeifferNasia Safdar
© 2021 Meta ULC. All rights reserved